Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
l-THP for Cocaine Use Disorder
NCT02139761Phase 2Withdrawn
- Sponsor
- University of Maryland, Baltimore
- Start
- Sep 2014
- Primary completion
- Jun 2016
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of tetrahydropalmatine in cocaine use disorder (CUD), sponsored by University of Maryland, Baltimore. Planned start Sep 2014; status: withdrawn.
02
Drugs
tetrahydropalmatine
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT02139761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02139761.